Lotus Pharmaceuticals, Inc. (LTUS)
Lotus Pharmaceuticals, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Irvine, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $82,311. On trailing twelve-month figures it carries a trailing P/E of -234.94, a net margin of 0.0%. Its beta of -1.60 implies it has historically moved less than the broad market.
Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Lotus Pharmaceuticals, Inc. is most often compared with the following Healthcare names: